Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: DNA Repair (Amst). 2013 Jul 27;12(10):835–843. doi: 10.1016/j.dnarep.2013.07.004

Genome instability and embryonic developmental defects in RMI1 deficient mice

Michel F Guiraldelli a, Craig Eyster a, Roberto J Pezza a,b,*
PMCID: PMC3797188  NIHMSID: NIHMS507768  PMID: 23900276

Abstract

RMI1 forms an evolutionarily conserved complex with BLM/TOP3α/RMI2 (BTR complex) to prevent and resolve aberrant recombination products, thereby promoting genome stability. Most of our knowledge about RMI1 function has been obtained from biochemical studies in vitro. In contrast, the role of RMI1 in vivo remains unclear. Previous attempts to generate an Rmi1 knockout mouse line resulted in pre-implantation embryonic lethality, precluding the use of mouse embryonic fibroblasts (MEFs) and embryonic morphology to assess the role of RMI1 in vivo. Here, we report the generation of an Rmi1 deficient mouse line (hy/hy) that develops until 9.5 days post coitum (dpc) with marked defects in development. MEFs derived from Rmi1hy/hy are characterized by severely impaired cell proliferation, frequently having elevated DNA content, high numbers of micronuclei and an elevated percentage of partial condensed chromosomes. Our results demonstrate the importance of RMI1 in maintaining genome integrity and normal embryonic development.

Keywords: homologous recombination, DNA repair, genome instability

1. Introduction

Unresolved or excess recombination products pose a significant threat to cell survival, while imprecise resolution of recombination intermediates may result in a number of chromosome rearrangements and genome instability. A highly regulated interplay between mechanisms that promote and suppress recombination is critical for genome stability, as well as suppression of cancer and premature aging. The BLM helicase and its yeast homolog Sgs1 have been implicated in preventing and resolving potentially mutagenic DNA structures that result in deleterious intermediates of recombination in both mitotic and meiotic cells, elevated sister chromatid exchange, and increased chromosomal rearrangements [1-8]. Bloom's syndrome is a human genetic disorder caused by mutations in BLM, which encodes one of the five known human RecQ helicases [9]. This condition is associated with predisposition to a diverse range of cancers and impaired development [10, 11]. Cells isolated from individuals with Bloom's syndrome [5], a Blm−/− conditional knockout in lymphocytes [12], and cells treated with siRNA specific for BLM [13, 14] are both characterized by chromosomal abnormalities and elevated levels of sister chromatid exchange, suggesting that the BLM protein is required to prevent and/or resolve mutagenic structures in vivo.

Consistent with the ability of BLM/Sgs1 to direct DNA recombination events away from deleterious intermediates, BLM and TOP3α together can dissolve a number of recombination intermediates in vitro [15-23]. Two recently described members of the BTR complex, RMI1 and RMI2 [13, 24-26], appear to stimulate its enzymatic functions [20, 22, 27-29]. Indeed, depletion of RMI1 results in increased levels of sister chromatid exchange similar to BLM knockdowns [13, 30]. Stability of the BTR complex is also dependent on RMI1 as depletion of RMI1 disrupts the BTR complex and decreases levels of its protein components, especially TOP3α [13, 24].

In addition to processing intermediates formed by recombination, more general roles for the BTR complex during DNA replication include the processing of stalled replication forks and the activation of the S-phase checkpoint under replication stress [31-33]. The latter may arise when the DNA replication machinery encounters obstructive DNA lesions and/or DNA secondary structures. Again, RMI1 plays an important role in this BTR function by mediating efficient recruitment of the complex to the stalled replication fork [31, 33, 34]. In addition it has recently been suggested that RMI1, independently of its function in the BTR complex, promotes progression of the replication fork [31].

Mouse knockouts for Blm and Top3α have been generated, and it has been reported that complete disruption of either of these genes results in embryonic lethality [14, 35]. Blm mutant embryos die at 13.5 days post coitum (dpc) and are delayed in development but display no obvious morphological abnormalities [14]. Furthermore, red blood cells and embryonic fibroblasts from Blm−/− mouse showed a large number of micronuclei and evidence of chromosome instability [14]. Top3α−/− embryos died at a pre-implantation stage and recovered blastocysts showed slow growth followed by a complete termination in proliferation [35]. Two previous attempts to generate an Rmi1 knockout mouse resulted in pre-implantation embryonic lethality [36, 37]. Thus, at present the in vivo requirements of mammalian RMI1 have only been studied in knockdowns obtained from siRNA-treated cultured cells. Here we report the generation of an Rmi1hy/hy mouse line that develops until 9.5 dpc. This allowed us to determine the requirement of RMI1 in normal embryonic development and, importantly, to obtain mouse embryonic fibroblasts (MEFs) to study the cellular phenotype that results from RMI1 depletion. We observed that cultured Rmi1hy/hy MEFs exhibit severely impaired cell proliferation and frequently show elevated DNA content. In addition, high numbers of micronuclei and an elevated percentage of partially condensed chromosomes are characteristic in these cells. These results indicate that RMI1 is important for maintaining genome integrity.

2. Materials and methods

2.1. Mice

An embryonic stem (ES) cell line (clone Rmi1Gt(PST18949)Mfgc) was purchased from the International Mouse Strain Resource (http://www.findmice.org/index.jsp). Injection into blastocyst and chimeric mouse generation were performed by the Toronto Centre for Phenogenomics (Toronto, Canada). C57BL/6 mice were purchased from Jax laboratories.

2.2. Dissection of embryos and genotyping

Heterozygous mice were bred to obtain wild-type, heterozygote (Rmi1wt/hy), and homozygous mutant (Rmi1hy/hy) embryos. Mice were kept on a 12 hour light-dark cycle. The morning of the day on which a vaginal plug was detected was designated 0.5 dpc. Embryos were dissected from the uterus in phosphate-buffered saline, and yolk sacs were used for genotyping by polymerase chain reaction (PCR). Yolk sacs were digested for 1 hour at 98°C in 25mM NaOH, 5mM EDTA followed by the same volume of 40mM Tris-HCl pH 5.5. Primers used for genotyping are illustrated on Figure 1A and their sequences shown on supplementary Table 1. PCR cycling conditions consisted of an initial denaturation at 94°C for 3 minutes; followed by 35 cycles of 94°C 30 seconds, 58°C 45 seconds, 72°C 50 seconds with a final extension step of 72°C for 5 minutes. Reactions were performed in an Applied Biosystems 2720 Thermal Cycler (Applied Biosystems) and products were analyzed on 1.5% agarose gel.

Fig. 1.

Fig. 1

Design and generation of the Rmi1hy/hy mice. (A) Scheme showing the gene trap strategy used to disrupt the Rmi1 gene. Exons (E) 1 through 3 are shown by filled boxes. The trapping cassette shows the splice acceptor (SA) the neomycin sequence (Neo) and the polyadenylation sequence (pA). Primers used for genotyping are indicated by arrows. (B) Agarose gel showing PCR products of the genotyping strategy. (C) Percentages of one month old wild-type (n=89), Rmi1wt/hy (n=146) and Rmi1hy/hy (n=0) adult mice obtained from Rmi1wt/hy intercrosses (235 total offspring analyzed). (D) Quantitative RT- PCR of Rmi1 expression in 9.5 dpc wild-type, Rmi1wt/hy and Rmi1hy/hy embryos. Primers used (qRmi1f and qRmi1r) are indicated by arrowheads in A. (E) Quantitative RT-PCR of expression of components of the BTR complex and control genes in 9.5 dpc wild-type and Rmi1hy/hy embryos. Primers used are described in supplementary Table 1.

2.3. Histological analysis

The uterine horns containing 9.5 dpc embryos were removed and placed in ice cold 1X PBS. Each embryo was separated by cutting between the implantation site and immediately transferred to 10% neutral-buffered formalin (Sigma) and fixed overnight. Fixed embryos were either processed for paraffin or cryo embedding. To access the embryonic morphology, paraffin serial-sections were stained with hematoxylin and eosin. Cryo serial sections were used to identify apoptotic cells by TUNEL assay (Roche) following manufacturer instructions. The detection of mitotic cells was done by immunostaining with the mitotic marker anti–phosphohistone H3 (pHH3) (Upstate). Cryo sections were blocked with 5% normal goat serum in PBS + 0.1% Triton for 2 hours at room temperature, immunostaining with pHH3 at 1:100 in blocking solution overnight at 4°C, washed 5 times in PBS + 0.1% Triton, incubated with a secondary antibody conjugated to Alexa 488 at 1:500 dilution for 45 minutes at room temperature, washed 5 times with PBS + 0.1% Triton. Slides were mounted with VectaShield containing DAPI. For genotyping of histological sections, the embryonic tissues were initially scraped from slides, transferred into DEXPAT reagent (TaKaRa) and genotyped by PCR.

2.4. Quantitative RT-PCR

After dissection, embryos were kept in 10 volumes of RNAlater stabilization reagent (Qiagen) at 4°C until genotyping from yolk sac was performed. Total RNA was extracted from wild-type, Rmiwt/hy and Rmi1hy/hy embryos using the RNeasy Mini Kit (Qiagen). 2μg of RNA was used to synthesize cDNA (High Capacity RNA-To-cDNA Kit, Applied Biosystem). SYBR® Green based quantitative PCR was carried out using Power SYBR® Green PCR Master Mix (Applied biosystems). Primers were designed to anneal to the boundaries of exon 2 (qRmi1F) and exon 3 (qRmi1R) of Rmi1. For quantitative RT-PCR of BTR complex components, primers were designed to anneal to the boundaries of exon 14 (qBlmF) and exon 15 (qBlmR) of Blm, exons 4 (qTop3aF) and 5 (qTop3aR) of Top3α, exons 1 (qRmi2F) and 2 of Rmi2 (qRmi2R), exons 7 (qAtmF) and 8 (qAtmR) of Atm, exons 2 (qAxin2F) and 3 (qAxin2R) of Axin2 (supplementary Table 1). A constitutive expression gene, β-actin, was used as endogenous control. Cycling conditions were: 95°C 10 minutes; 95°C 10 seconds, 60°C 30 seconds, for 40 cycles. The melting curve was obtained under conditions of 95°C 10 sec and 65°C to 95°C performed in increments of 0.5°C 5 seconds, in a BioRad CFX96 thermocycler. The comparative threshold cycle method (Ct) was used to determine the relative fold change in gene expression and β-actin was used as internal control. Four independent experiments were used to compile data and present as a mean with standard deviation. Two-tailed student t-test was used for statistics analysis.

2.5. EdU incorporation

DNA synthesis was accessed by incorporation of EdU (Click-iT Imaging Kit, Invitrogen). After 17 days in culture, 3×104 MEFs were inoculated onto 13cm round glass coverslip and allowed to adhere for 24 hours. Then, cells were incubated with 5μg/ml of EdU (Invitrogen) for 2, 4, 8 and 24 hours and washed in PBS 1X twice. Finally, MEFs were fixed in 4% paraformaldehyde for 15 minutes at room temperature. Detection of EdU was performed following the manufacturer instructions. DNA was visualized with DAPI staining.

2.6. Flow cytometry

Cells from wild-type and Rmi1hy/hy embryos were fixed in 70% ethanol and kept at – 20°C until analysis. Briefly, after centrifugation the cell pellet was washed with PBS 1X and resuspended in 500μl Krishnan's reagent (0.1 mg/ml propidium iodide, 0.02 mg/ml RNase A, 0.3% NP-40 and 0.1% Na citrate) and incubated in the dark for 20 minutes at 25°C. Data acquisition was carried out using FACSCalibur and analyzed using the FloJo Cell Cycle analysis software. In addition, DNA ploidy (N) and cell cycle phases were determined [38].

2.7. Cell counting

Cell Growth curves were performed by a manual count method to determine the proliferative rate of mouse embryonic fibroblasts. Cells were seeded at 1 × 104 cells/well in a 24-well tissue culture plate (Greiner) and viable cells were counted daily by the Trypan blue dye exclusion method.

2.8. Micronuclei assay and nuclear morphometry

After 17 days in culture, 3×104 cells were inoculated onto 13cm round glass coverslips and allowed to adhere for 24 hours. Cells were washed in PBS 1X, fixed with 4% paraformaldehyde for 30 minutes and then permeabilized with 0.5% Triton X-100 in PBS 1X for 5 minutes on ice. After, two washes with 1X PBS, nuclei were stained with DAPI. The number of micronuclei was manually counted and the nuclear area was determined automatically using AxioVision 4.8 software. Micronuclei were identified as those with a diameter of less than 1/3 of normal nuclei.

2.9. Metaphase spreads

Metaphase spreads were done as previously described [39]. Immediately after dissection, embryos were washed briefly with 1X PBS followed by incubation with nocodazol 200ng/ml for 4 hours. Embryos were then transferred to a hypotonic solution (0.56% KCl) for 30 minutes at room temperature followed by overnight fixation in ice cold methanol:acetic acid (3:1). Dissociation of the embryos was carried out in 60% acetic acid at 4°C. Dissociated embryos were centrifuged at 1000Xg for 5 minutes, resuspended in fixative solution (3:1 methanol:acetic acid) and transferred to slides. Metaphase spreads were stained with Giemsa. After washing with Gur's buffer (Invitrogen), the spreads were mounted in Permount.

2.10. Gamma irradiation and γH2AX immunostaining

After 17 days in culture, MEFs derived from both wild-type and Rmi1hy/hy embryos were transferred to coverslips and allowed to adhere overnight in a 37°C incubator with 5% CO2. Coverslips were transferred to a plate containing fresh medium and exposed to 50Gy of gamma irradiation using a gamma cell irradiator at 0.5Gy per minute. After irradiation, coverslips containing cells were returned to the incubator and collected at the time points indicated. Non irradiated cells were used as a control. Cells were fixed in 4% paraformaldehyde for 20 minutes, permeabilized with 0.5% Triton in PBS 1X for 20 min and washed with PBS 1X. Cells were blocked with 4% BSA in PBS 1X for 30 minutes at room temperature, followed by incubation with anti-γH2AX (Millipore) at 1:1000 dilution for 2 hours at room temperature. Secondary antibody conjugated to Alexa 596 was used at 1:500 dilution for 30 minutes at room temperature. Analysis of anti-γH2AX image intensity was performed using MetaMorph 6.3 software (Molecular Devices Corporation).

3. Results

3.1. Generation of RMI1 deficient mice

We generated a mouse line with a gene trap-disrupted allele, Rmi1Gt(PST18949)Mfgc (Figure 1A). The ES cell contained a gene trap vector inserted into intron 1, flanked by exon 1 and 2 of Rmi1 gene located on chromosome 13. Exons 1 and 2 are non-coding exons, but necessary for the expression of Rmi1. PCR analysis was used to identify animals that were wild-type (346bp PCR product), heterozygous (wt/hy, 346bp and 478bp products) and homozygous (hy/hy, 478bp product) (Figure 1A and B). Rmi1wt/hy are fertile, did not display any apparent tissue anomaly, showed no sign of shortened life span and did not display evidence of tumor development up to 20 months of age.

3.2. RMI1 deficiency leads to embryonic lethality in mice

The genotyping of 235 offspring from 39 different litters yielded no viable Rmi1hy/hy (Figure 1C). The absence of Rmi1hy/hy among the litters indicates that the homozygous disruption of Rmi1 is embryonic lethal in mice. To investigate the developmental stage at which lethality occurs we carried out timed matings. Pregnant mice were euthanized at 8.5, 9.5, 10.5 and 11.5 dpc. After embryonic dissection, the genotype of each embryo was determined by PCR analysis of the yolk sac. Live Rmi1hy/hy embryos were detected from 8.5 dpc to 9.5 dpc with a genotype distribution of the expected Mendelian ratios. At 10.5 dpc only Rmi1hy/hy embryos undergoing degeneration or almost absorbed were detected, suggesting that they died at 9.5 dpc (Table 1). Analysis of Rmi1 mRNA expression in 9.5 dpc embryos was assessed by quantitative real time PCR. Compared to wild-type littermates, we observed approximately 5% of mRNA expression in Rmi1hy/hy (a characteristic of hypomorph mutants). Heterozygous embryos expressed approximately half the mRNA of that observed for wild-type (Figure 1D).

Table 1.

Proportion of wild-type, Rmi1wt/hy and Rmi1hy/hy embryos obtained from time mating Rmi1wt/hy intercrosses.

Number of embryos obtained from Rmi1+/− intercrosses
dpc Wild-type Rmi1wt/hy Rmihy/hy Resorption Total
11.5 16 (36.3%)±1.1 25 (56.8%)±1.2 0 3 (6.8%)±0.8 44
10.5 24 (30.7%)±0.7 43 (55.1%)±0.9 1 (1.2%)±0.3 10 (12.8%)±0.8 78
9.5 36 (23.2%)±1.2 74 (47.7%)±1.9 33 (21.2%)±1.2 12 (7.7%)±0.9 155
8.5 14 (29.1%) ±0.8 21 (43.7%) ±2.2 9 (18.7) ±0.8 4 (8.3%) ±0.8 48

We used RT-PCR and mRNA obtained from Rmi1hy/hy and wild-type littermates to determine the level of expression of Blm, Topo3α, Rmi1 and Rmi2. Compared to the wild-type, Rmi1hy/hy cells showed significantly decreased expression of Blm, (0.46 ± 0.02, n=16), Topo3α (0.39 ±0.13, n=16), and Rmi2 (0.60 ± 0.07, n=16). This is in agreement with previous work showing that depletion of RMI1 results in a decrease in the components of the BTR protein complex [13, 24]. As expected, we detected marginal expression of Rmi1, and observed no changes in the level of expression of genes non-related to the BTR complex (Atm, 0.91 ± 0.12, n=16; Axin2, 1.19 ± 0.05, n=3 and 18s 0.98 ± 0.121, n=6).

3.3. RMI1 deficiency leads to severe embryonic development delay, low mitotic index and extensive apoptosis

Macroscopic analysis of 8.5 dpc Rmi1hy/hy embryos and wild-type littermates showed no developmental differences (data not shown). However, gross growth and morphological characteristics became overt by 9.5 dpc. In sharp contrast to the wild-type, 9.5 dpc Rmi1hy/hy embryos were distinctly smaller, most of them had not undergone axial rotation, showed a severe development delay (Figure 2A), and yolk sacs did not show a normal pattern of vascularization (data not shown). Histological analysis of 9.5 dpc Rmi1hy/hy embryos showed lack of limb bud formation, opened neural tube and a defined tail-bud structure suggesting that the development of Rmi1hy/hy embryos is interrupted at 8.5 dpc (Figure 2B).

Fig. 2.

Fig. 2

Rmi1hy/hy embryos exhibit development delay and elevated numbers of apoptotic cells. (A) Macroscopic analysis of wild-type, Rmi1wt/hy and Rmi1hy/hy 9.5 dpc embryos. (B) Histological analysis of hematoxylin & eosin-stained wild-type and Rmi1hy/hy embryos. Hind limb buds (arrows) and unclosed neural tube (arrow head) are indicated. (C) Note increased numbers of TUNEL positive cells (an indication of apoptosis. Green cells) in Rmi1hy/hy with respect to wild-type. Insets show higher magnification of areas with apoptotic cells.

We performed TUNEL assays on sections of 9.5 dpc wild-type and Rmi1hy/hy embryos to determine the presence of apoptotic cells. The number of apoptotic cells in Rmi1hy/hy was notably higher than that of wild-type embryos, indicating that at 9.5 dpc, Rmi1hy/hy embryos suffer massive cell death (Figure 2C).

3.4. RMI1 deficiency results in severely impaired cell proliferation and elevated DNA content

RMI1, in the context of the BTR complex, promotes processing of some intermediates of DNA recombination repair (i.e., Holliday junctions) and promotes re-initiation of collapsed replication forks. Elimination of excess recombination, which is essential for the maintenance of genome stability, and the completion of DNA replication are required in the normal cell cycle. We therefore reasoned that deletion of RMI1 might result in alteration of cell proliferation. To test this hypothesis we obtained MEFs from Rmi1hy/hy embryos at 8.5 and 9.5 dpc. During a seven day-growth period wild-type MEFs proliferated normally, however cell growth was severely impaired in Rmi1hy/hy MEFs of both 9.5 dpc (Figure 3A) and 8.5dpc embryos (data not shown). We did not observe signal of cell proliferation in Rmi1hy/hy cells cultured for periods of up to six months (results not shown). We also tested the effect of the protein phosphatase inhibitor okadaic acid on cultured MEFs. Okadaic acid has been described to act as a stimulator of proliferation with effects on cell cycle checkpoints, i.e. accelerate G2/Mitosis I progression [40, 41]. Cell arrest in Rmi1hy/hy is apparently irreversible, as cultured MEFs do not undergo mitosis even after treatment with okadaic acid (data not shown). This precluded further analysis of sister chromatid exchange to assess whether, as previously observed for BLM deficient cells [11], loss of RMI1 may lead to chromosome instability.

Fig. 3.

Fig. 3

Proliferation defects in MEFs from Rmi1hy/hy embryos. (A) Growth curve showing proliferation of mouse embryonic fibroblasts derived from wild-type (n=6, number of embryos), Rmi1wt/hy (n=8) and Rmi1hy/hy (n=5) 9.5 dpc embryos. The number of cells is plotted relative to the initial number of cells counted (1 × 104 cells for wild-type, Rmi1wt/hy and Rmi1hy/hy). (B) Image of wild-type and Rmi1hy/hy MEFs showing EdU incorporation. Cells that incorporated EdU are green. DAPI staining is in grey. (C) Incorporation of EdU by wild-type and Rmi1hy/hy MEFs is plotted as a percentage of cells containing EdU in their nuclei after various times of incubation. Error bars show the standard deviation of the mean. (D) Frozen sections of 9.5 dpc embryos immunostained with anti phospho-histone H3 (green cells). DAPI staining is in green.

We measured cell incorporation of EdU to determine whether the severely impaired cell proliferation in Rmi1hy/hy MEFs is accompanied by deficient DNA replication. After 18 days in culture, wild-type and Rmi1hy/hy MEFs were incubated with EdU for 2, 4, 8 and 24 hours (Figure 3B and C). In sharp contrast to wild-type cells, in which incorporation of EdU was detected in 35% of the cells, only a maximum of 1.6% of Rmi1hy/hy MEFs were EdU positive after 24-hour incubation (Figure 3C and Table 2).

Table 2.

The mean and standard deviation of wild-type and Rmi1hy/hy cells incorporating EdU.

Genotype
EdU incorporation (hours) Wild-type (% EdU positive cells) N Rmi1hy/hy (% EdU positive cells) N
2 15.1±4.2 600 1.7±0.4b 400
4 22.9±3.0 600 1.5±1.4b 400
8 27.2±3.2 600 1.7±1.3b 400
24 35.1±1.4 600 1.6±0.6a 400
a

Significantly different from wild-type(p≤0.0001, t test).

b

Significantly different from wild-type(p≤0.0053, t test).

We also performed immunostaining of 9.5 dpc embryo frozen sections using anti-pHH3, a marker of mitotic cells. Our results revealed that cell proliferate actively in wild-type embryos, however only few mitotic cells can be observed in Rmi1hy/hy embryos (Figure 3D).

Flow cytometry analysis of asynchronous MEFs after 18 days of culture (approximately 20, 000 cells per condition assayed) revealed that in contrast to wild-type (14.8% ± 4.0, n=5 number of tested embryos) a higher proportion of Rmi1hy/hy cells show apparent 4N DNA content (31.6% ± 7.6, n=7) (p=0.0012, unpaired t-test). Remarkably, the number of polyploidy in Rmi1hy/hy MEFs (>4N; 13% ± 4.1, n=7) is higher than in wild-type (2.2% ± 0.3, n=5) (p=0.0002, unpaired t-test) (Figure 4A and B). Wild-type and Rmi1hy/hy cells from freshly dissociated 9.5 dpc embryos did not show significant difference in ploidy (Supplementary Figure 2A and 2B). We also observed that the average nuclear area of Rmi1hy/hy MEFs was significantly higher 576.9μm2 ± 272.6 (n=485) than those of wild-type 261.2μm2 ± 85 (n=459) (p<0.0001, Mann-Whitney test) (Figure 4C and D). Taken together our results indicate that RMI1 depletion results in general DNA replication arrest. However, a portion of Rmi1hy/hy cells are able to at least partially replicate DNA without entering mitosis, which results in high DNA content per nucleus. This is a potential explanation for the severe deficiency in cell proliferation observed in Rmi1hy/hy embryos.

Fig. 4.

Fig. 4

Elevated DNA content and nuclear area in Rmi1hy/hy MEFs. (A) A representative result from flow cytometry analysis of DNA content in asynchronous wild-type and Rmi1hy/hy cultured MEFs. (B) DNA content analysis of asynchronous cultured MEFs shown as a percentage of cells with different DNA content. MEFs obtained from different embryos (wild-type embryos n=5, Rmi1hy/hy MEFs n=7) were used to replicate the results obtained. Error bars show the standard deviation of the mean. (C) Examples of wild-type and Rmi1hy/hy MEFs stained with DAPI showing differences in nuclear area. (D) Distribution of nuclear area in wild-type and Rmi1hy/hy MEFs.

3.5. Genome instability and incomplete chromosome condensation in RMI1 deficient MEFs

The severely impaired cell proliferation in Rmi1hy/hy cultured MEFs may be also caused by genome instability. To test this possibility we determined the number of micronuclei in MEFs, which represent whole or fragmented chromosomes separated from the main nucleus [42, 43]. Cultured Rmihy/hy MEFs show a higher proportion of micronuclei (56% ± 6.4, n=485) compared to wild-type cells (12% ± 4.7, n=459) (p=0.0007, t-test) (Figure 5A-C). The estimated number of micronuclei per cell averaged 1.1 in Rmi1hy/hy cells in contrast to 0.14 in wild-type cells. We also observed significant differences in the distribution of the number of micronuclei per cell when comparing the population of wild-type and Rmi1hy/hy (p=0.0776, Mann-Whitney test). Significant differences were also observed when we compared fractions of cell populations in wild-type versus Rmi1hy/hy containing zero micronuclei (p=0.0013, paired two tailed t-test analysis), 1 micronuclei (p=0.0352), 2 micronuclei (p=0.0045) and 3 micronuclei (p=0.0040) (Figure 5C). Cytochalasin B treatment did not significantly change the number of counted micronuclei per cell. A high percentage of Rmi1hy/hy cells obtained from freshly dissociated embryos contained micronuclei (43.1% ± 7.1, n=160) compared to wild-type (18.6% ± 4.1, n=160) (p=0.0068, t-test). As per the distribution of micronuclei in fresh dissociated cells, significant differences were observed only in cells containing zero micronuclei (p=0.0474, paired two tailed t-test), 2 micronuclei (p=0.0374) and 3 micronuclei (p=0.0374) (Supplementary Figure 2A-C).

Fig. 5.

Fig. 5

Genome instability in Rmi1hy/hy deficient cells. (A) Representative wild-type and Rmi1hy/hy MEFs stained with DAPI. Note the presence of micronuclei (arrows) in mutant cells. (B) Quantitation of wild-type and Rmi1hy/hy cells containing at least one micronucleus. (C) Distribution of the number of micronuclei per cell in wild-type and Rmi1hy/hy MEFs populations. (D) Examples of metaphase spreads showing normally condensed chromosomes in wild-type and incompletely condensed chromosomes in Rmi1hy/hy MEFs from 9.5 dpc embryos. (E) Quantitation of normal and partially condensed chromosomes from wild-type and Rmi1hy/hy metaphase spreads.

It is also possible that the proliferation defect observed in Rmi1hy/hy MEFs may have its origin in chromosome abnormalities. Chromosome spreads prepared from freshly dissociated 9.5 dpc embryos treated with nocodazole showed that, in sharp contrast to wild-type (4.6% ± 0.6% n=768 metaphase), approximately 30% ± 4.4% of Rmi1hy/hy cells (n=835) (p=0.0002, unpaired t-test) contained partially condensed chromosomes (Figure 5D and E). These cells are negative for TUNEL assay (not shown), indicating that apoptosis may not be the cause of partial chromosome condensation.

3.6. Double-strand break repair in Rmi1hy/hy MEFs

Double-strand break repair can be used as a tool to investigate the ability of cells to repair damaged DNA. We induced double-strand breaks by gamma irradiation and followed their repair by monitoring γH2AX immunostaining. We observed a background signal for γH2AX immunostaining, perhaps resulting from replication and/or spontaneous damage in non-irradiated wild-type and Rmi1hy/hy MEFs. After irradiation (50 Gy), wild-type and Rmi1hy/hy cells showed a peak γH2AX signal at 1 hour and displayed similar kinetics of γH2AX signal disappearance (Figure 6). Our results indicate that depletion of RMI1 does not affect the repair of the bulk of double-strand breaks introduced by gamma irradiation. However, the outcome of double-strand break repair, i.e. higher number of crossovers in Rmi1hy/hy, remains to be determined.

Fig. 6.

Fig. 6

Kinetics of irradiation induced double-strand break repair in wild-type and Rmi1hy/hy MEFs. Intensity of immunosignal for γH2AX is plotted at the indicated times in irradiated and non-irradiated (NI) MEFs.

4. Discussion

Most of our knowledge about RMI1 function(s) has been obtained from in vitro biochemical studies. The in vivo role of RMI1, in contrast, remains understudied. Previous attempts to generate Rmi1hy/hy mouse resulted in pre-implantation embryonic lethality. This impeded the use of MEFs and embryonic morphology to assess the in vivo role of RMI1. The mouse model constructed in this study contains a gene trap cassette inserted in the intron flanked by exons 1 and 2, which are non-coding exons. However, the stop codon present on the trap cassette disrupts the transcription of Rmi1. The generated mouse allowed us to analyze initial stages of embryonic development and the cellular phenotype of Rmi1hy/hy MEFs. We conclude that RMI1 is essential for normal embryonic development, cell viability and genome stability.

We have shown that our Rmi1hy/hy mice died at 9.5 dpc. This phenotype is significantly less severe than two Rmi1 mutant mice reported previously, which die before implantation [36, 37]. A number of possible reasons could account for this difference. First, genetic backgrounds and distinct target mutations may have an effect on the phenotypes of all three Rmi1hy/hy strains. For example, Chen's knockout [37] was created by deleting the third exon of Rmi1, as opposed to the disruptive gene trap insertion between exon 1 and 2 in our mice. An alternative explanation for the longer embryonic life of our mice could be attributed to low levels of Rmi1 expression, as indicated by quantitative PCR analysis (5% of expression with respect to wild-type). This could be an indicator of an Rmi1 mutation that is not null but hypomorphic.

Knockout mice for other members of the BTR complex have also been generated. Complete inactivation of the BLM loci resulted in embryonic growth retardation with no morphological abnormalities, and lethality at 13.5 dpc [14]. Compared with Blm−/− mice, embryonic lethality in our Rmi1hy/hy mice occurred at a much earlier stage and was accompanied by a development arrest. A possible explanation for these differences is that RMI1 might be playing an additional role that is independent from its role together with BLM. Supporting this argument is the fact that RMI1 but not BLM is required for normal replication progression [31], and RMI1 can form BLM-independent complexes with TOP3α and RMI2 [24, 44, 45]. Indeed, the ability of RMI1 to interact and regulate TOP3α function may partially explain the earlier embryonic lethality observed for Rmi1hy/hy with respect to Blm−/−. In agreement with this, the Top3α−/− exhibits a pre-implantation embryonic lethality [35]. Finally, the fact that RMI1 is required for the stability of other components of the BTR complex should also be considered. Loss of RMI1 resulted in decreased expression of all members of the BTR complex (Figure 1E), which lead to reduced levels of BLM, TOP3α and RMI2 proteins [13, 24, 26]. Therefore it is possible that the phenotype of Rmi1hy/hy may result from a compounded deficit of RMI1, TOP3α and BLM.

What is the cause of embryonic lethality in Rmihy/hy embryos? Our data reveal several major defects that may contribute to embryonic lethality. First, MEFs from Rmi1hy/hy embryos exhibited severely impaired cell proliferation. This agrees with previous reports showing a prominent decrease in cell proliferation in HeLa and HCT116 cells treated with siRNA specific for Rmi1 [13, 37]. This cell proliferation defect is also observed in mammalian and yeast cells after knockdown or deletion of other components of the BTR complex such as BLM or TOP3α [12, 14, 27]. The severely impaired proliferation in Rmi1hy/hy cells may result from a requirement for RMI1 in DNA replication. Indeed, it was recently reported that RMI1 plays an important role in DNA replication progression, and when associated with BLM, and TOP3α mediates the recovery of replication fork stress and fork progression [31, 32, 46]. Furthermore, yeast depleted of RMI1 accumulate in G2/M [30] and persistent activation of this checkpoint probably accounts for the G2/M delay observed in cells treated with DNA replication inhibitors [47]. Interestingly, after 18 days in culture Rmi1hy/hy cells show abnormally high DNA content. These ploidy problems could arise from mitotic chromosome missegregation. However, these cells are severely impaired in proliferation and do not undergo mitosis. Therefore, we favor the view in which Rmi1hy/hy cells replicate DNA without entering mitosis. An alternative possible cause of the proliferation defect in Rmi1hy/hy cells is genome instability. Indeed, we observed that Rmi1hy/hy MEFs show an increase in the number of micronuclei, a classical indication of genome instability [42, 43, 48]. This extensive genetic instability may also serve as a primary reason for the death of mutant embryos.

We also note a high proportion of loosely compacted chromosomes in Rmi1hy/hy metaphase cells. Poor chromosome condensation may interfere with normal progression of the remaining phases of mitosis and consequently lead to cell arrest. We observed that a major fraction of cells containing partially condensed chromosomes were negative for TUNEL staining, and the ability of Rmi1 deficient cells to repair DSBs introduced by gamma irradiation is apparently indistinguishable from wild-type (Figure 6). These results indicate that apoptosis and/or inability to repair DNA damage may not be the cause of the failure of Rmi1 deficient cells to condense chromosomes. We favor an alternative possible scenario in which deficient DNA replication may be the cause of poor chromosome condensation. Indeed, recent reports show that RMI1 plays an important role in DNA replication progression and when associated with BLM and TOP3α mediates the recovery of replication fork stress and fork progression [31, 32, 46].

In summary, our data shows that RMI1 is required for embryonic development, and provides insight into the poorly understood cellular functions of RMI1 on cell proliferation and in maintaining genome stability. Future studies of RMI1 function will focus on determining BTR-dependent and independent roles of RMI1.

Supplementary Material

01
02
03
04

Highlights.

  • Deletion of Rmi1 in mice results in embryonic developmental defects.

  • Rmi1hy/hy MEFs exhibit genome instability and severely impaired cell proliferation.

  • RMI1 action is crucial for mechanisms that maintain genome stability.

Acknowledgments

We thank Christopher Sansam, Courtney Griffin and John Knight for critical reading of the manuscript. We are grateful to Courtney Sansam for help in analyzing flow cytometry results, and Courtney Griffin for assistance with RT-PCR and embryo dissection. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number 1P20GM103636 to R. J. P.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References

  • 1.Myung K, Datta A, Chen C, Kolodner RD. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination. Nat Genet. 2001;27:113–116. doi: 10.1038/83673. [DOI] [PubMed] [Google Scholar]
  • 2.Chaganti RS, Schonberg S, German J. A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc Natl Acad Sci U S A. 1974;71:4508–4512. doi: 10.1073/pnas.71.11.4508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wang W, Seki M, Narita Y, Sonoda E, Takeda S, Yamada K, Masuko T, Katada T, Enomoto T. Possible association of BLM in decreasing DNA double strand breaks during DNA replication. Embo J. 2000;19:3428–3435. doi: 10.1093/emboj/19.13.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mankouri HW, Hickson ID. Understanding the roles of RecQ helicases in the maintenance of genome integrity and suppression of tumorigenesis. Biochem. Soc. Trans. 2004;32:957–958. doi: 10.1042/BST0320957. [DOI] [PubMed] [Google Scholar]
  • 5.German J. Cytological Evidence for Crossing-over in Vitro in Human Lymphoid Cells. Science. 1964;144:298–301. doi: 10.1126/science.144.3616.298. [DOI] [PubMed] [Google Scholar]
  • 6.Jessop L, Rockmill B, Roeder GS, Lichten M. Meiotic chromosome synapsis-promoting proteins antagonize the anti-crossover activity of sgs1. PLoS genetics. 2006;2:e155. doi: 10.1371/journal.pgen.0020155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dayani Y, Simchen G, Lichten M. Meiotic recombination intermediates are resolved with minimal crossover formation during return-to-growth, an analogue of the mitotic cell cycle. PLoS Genet. 2011;7:e1002083. doi: 10.1371/journal.pgen.1002083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.De Muyt A, Jessop L, Kolar E, Sourirajan A, Chen J, Dayani Y, Lichten M. BLM helicase ortholog Sgs1 is a central regulator of meiotic recombination intermediate metabolism. Mol. Cell. 2012;46:43–53. doi: 10.1016/j.molcel.2012.02.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M, German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell. 1995;83:655–666. doi: 10.1016/0092-8674(95)90105-1. [DOI] [PubMed] [Google Scholar]
  • 10.German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore) 1993;72:393–406. [PubMed] [Google Scholar]
  • 11.Payne M, Hickson ID. Genomic instability and cancer: lessons from analysis of Bloom's syndrome. Biochem. Soc. Trans. 2009;37:553–559. doi: 10.1042/BST0370553. [DOI] [PubMed] [Google Scholar]
  • 12.Babbe H, Chester N, Leder P, Reizis B. The Bloom's syndrome helicase is critical for development and function of the alphabeta T-cell lineage. Mol. Cell. Biol. 2007;27:1947–1959. doi: 10.1128/MCB.01402-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Yin J, Sobeck A, Xu C, Meetei AR, Hoatlin M, Li L, Wang W. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. Embo J. 2005;24:1465–1476. doi: 10.1038/sj.emboj.7600622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chester N, Kuo F, Kozak C, O'Hara CD, Leder P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev. 1998;12:3382–3393. doi: 10.1101/gad.12.21.3382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wu L, Hickson ID. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature. 2003;426:870–874. doi: 10.1038/nature02253. [DOI] [PubMed] [Google Scholar]
  • 16.Plank JL, Wu J, Hsieh TS. Topoisomerase IIIalpha and Bloom's helicase can resolve a mobile double Holliday junction substrate through convergent branch migration. Proc Natl Acad Sci U S A. 2006;103:11118–11123. doi: 10.1073/pnas.0604873103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hickson ID. RecQ helicases: caretakers of the genome. Nat Rev Cancer. 2003;3:169–178. doi: 10.1038/nrc1012. [DOI] [PubMed] [Google Scholar]
  • 18.Bugreev DV, Yu X, Egelman EH, Mazin AV. Novel pro- and anti-recombination activities of the Bloom's syndrome helicase. Genes Dev. 2007;21:3085–3094. doi: 10.1101/gad.1609007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bugreev DV, Mazina OM, Mazin AV. Bloom syndrome helicase stimulates RAD51 DNA strand exchange activity through a novel mechanism. J Biol Chem. 2009;284:26349–26359. doi: 10.1074/jbc.M109.029371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Raynard S, Bussen W, Sung P. A double Holliday junction dissolvasome comprising BLM, topoisomerase IIIalpha, and BLAP75. J. Biol. Chem. 2006;281:13861–13864. doi: 10.1074/jbc.C600051200. [DOI] [PubMed] [Google Scholar]
  • 21.Raynard S, Zhao W, Bussen W, Lu L, Ding YY, Busygina V, Meetei AR, Sung P. Functional role of BLAP75 in BLM-topoisomerase IIIalpha-dependent holliday junction processing. J. Biol. Chem. 2008;283:15701–15708. doi: 10.1074/jbc.M802127200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bussen W, Raynard S, Busygina V, Singh AK, Sung P. Holliday junction processing activity of the BLM-Topo IIIalpha-BLAP75 complex. J. Biol. Chem. 2007;282:31484–31492. doi: 10.1074/jbc.M706116200. [DOI] [PubMed] [Google Scholar]
  • 23.Daley JM, Niu H, Sung P. Roles of DNA helicases in the mediation and regulation of homologous recombination. Adv Exp Med Biol. 2013;767:185–202. doi: 10.1007/978-1-4614-5037-5_9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Xu D, Guo R, Sobeck A, Bachrati CZ, Yang J, Enomoto T, Brown GW, Hoatlin ME, Hickson ID, Wang W. RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability. Genes Dev. 2008;22:2843–2855. doi: 10.1101/gad.1708608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, Joenje H, Hoatlin ME, Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol. 2003;23:3417–3426. doi: 10.1128/MCB.23.10.3417-3426.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Singh TR, Ali AM, Busygina V, Raynard S, Fan Q, Du CH, Andreassen PR, Sung P, Meetei AR. BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component of the Bloom helicase-double Holliday junction dissolvasome. Genes Dev. 2008;22:2856–2868. doi: 10.1101/gad.1725108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mullen JR, Nallaseth FS, Lan YQ, Slagle CE, Brill SJ. Yeast Rmi1/Nce4 controls genome stability as a subunit of the Sgs1-Top3 complex. Mol. Cell. Biol. 2005;25:4476–4487. doi: 10.1128/MCB.25.11.4476-4487.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cejka P, Plank JL, Bachrati CZ, Hickson ID, Kowalczykowski SC. Rmi1 stimulates decatenation of double Holliday junctions during dissolution by Sgs1-Top3. Nat Struct Mol Biol. 2010;17:1377–1382. doi: 10.1038/nsmb.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yang J, Bachrati CZ, Ou J, Hickson ID, Brown GW. Human topoisomerase IIIalpha is a single-stranded DNA decatenase that is stimulated by BLM and RMI1. J Biol Chem. 2010;285:21426–21436. doi: 10.1074/jbc.M110.123216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chang M, Bellaoui M, Zhang C, Desai R, Morozov P, Delgado-Cruzata L, Rothstein R, Freyer GA, Boone C, Brown GW. RMI1/NCE4, a suppressor of genome instability, encodes a member of the RecQ helicase/Topo III complex. Embo J. 2005;24:2024–2033. doi: 10.1038/sj.emboj.7600684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yang J, O'Donnell L, Durocher D, Brown GW. RMI1 Promotes DNA Replication Fork Progression and Recovery from Replication Fork Stress. Mol Cell Biol. 2012 doi: 10.1128/MCB.00255-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ralf C, Hickson ID, Wu L. The Bloom's syndrome helicase can promote the regression of a model replication fork. J. Biol. Chem. 2006;281:22839–22846. doi: 10.1074/jbc.M604268200. [DOI] [PubMed] [Google Scholar]
  • 33.Hoadley KA, Xue Y, Ling C, Takata M, Wang W, Keck JL. Defining the molecular interface that connects the Fanconi anemia protein FANCM to the Bloom syndrome dissolvasome. Proc Natl Acad Sci U S A. 2012;109:4437–4442. doi: 10.1073/pnas.1117279109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Deans AJ, West SC. FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia. Mol Cell. 2009;36:943–953. doi: 10.1016/j.molcel.2009.12.006. [DOI] [PubMed] [Google Scholar]
  • 35.Li W, Wang JC. Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis. Proc Natl Acad Sci U S A. 1998;95:1010–1013. doi: 10.1073/pnas.95.3.1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Suwa A, Yoshino M, Yamazaki C, Naitou M, Fujikawa R, Matsumoto S, Kurama T, Shimokawa T, Aramori I. RMI1 deficiency in mice protects from diet and genetic-induced obesity. FEBS J. 2010;277:677–686. doi: 10.1111/j.1742-4658.2009.07513.x. [DOI] [PubMed] [Google Scholar]
  • 37.Chen H, You MJ, Jiang Y, Wang W, Li L. RMI1 attenuates tumor development and is essential for early embryonic survival. Mol Carcinog. 2011;50:80–88. doi: 10.1002/mc.20694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Darzynkiewicz Z. Critical aspects in analysis of cellular DNA content. Curr Protoc Cytom. 2011 doi: 10.1002/0471142956.cy0702s56. Chapter 7 Unit 7 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wang RH, Sengupta K, Li C, Kim HS, Cao L, Xiao C, Kim S, Xu X, Zheng Y, Chilton B, Jia R, Zheng ZM, Appella E, Wang XW, Ried T, Deng CX. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008;14:312–323. doi: 10.1016/j.ccr.2008.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ghosh S, Schroeter D, Paweletz N. Okadaic acid overrides the S-phase check point and accelerates progression of G2-phase to induce premature mitosis in HeLa cells. Exp Cell Res. 1996;227:165–169. doi: 10.1006/excr.1996.0262. [DOI] [PubMed] [Google Scholar]
  • 41.Wiltshire T, Park C, Caldwell KA, Handel MA. Induced premature G2/M-phase transition in pachytene spermatocytes includes events unique to meiosis. Dev Biol. 1995;169:557–567. doi: 10.1006/dbio.1995.1169. [DOI] [PubMed] [Google Scholar]
  • 42.Chu WK, Hickson ID. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer. 2009;9:644–654. doi: 10.1038/nrc2682. [DOI] [PubMed] [Google Scholar]
  • 43.Fenech M. The micronucleus assay determination of chromosomal level DNA damage. Methods Mol Biol. 2008;410:185–216. doi: 10.1007/978-1-59745-548-0_12. [DOI] [PubMed] [Google Scholar]
  • 44.Guo R, Xu D, Wang W. Identification and analysis of new proteins involved in the DNA damage response network of Fanconi anemia and Bloom syndrome. Methods. 2009;48:72–79. doi: 10.1016/j.ymeth.2009.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chen CF, Brill SJ. Binding and activation of DNA topoisomerase III by the Rmi1 subunit. J Biol Chem. 2007;282:28971–28979. doi: 10.1074/jbc.M705427200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wu L, Bachrati CZ, Ou J, Xu C, Yin J, Chang M, Wang W, Li L, Brown GW, Hickson ID. BLAP75/RMI1 promotes the BLM-dependent dissolution of homologous recombination intermediates. Proc. Natl. Acad. Sci. U. S. A. 2006;103:4068–4073. doi: 10.1073/pnas.0508295103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Ashton TM, Mankouri HW, Heidenblut A, McHugh PJ, Hickson ID. Pathways for Holliday junction processing during homologous recombination in Saccharomyces cerevisiae. Mol. Cell. Biol. 2011;31:1921–1933. doi: 10.1128/MCB.01130-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rosin MP, German J. Evidence for chromosome instability in vivo in Bloom syndrome: increased numbers of micronuclei in exfoliated cells. Hum Genet. 1985;71:187–191. doi: 10.1007/BF00284570. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01
02
03
04

RESOURCES